The aim is to evaluate if internet- delivered cognitive behavior therapy (CBT), based on exposure principles and behavioral activation, improves QoL and symptom burden in patients with symptomatic atrial fibrillation (AF) compared to treatment as usual. The study will include 120 patients with symptomatic AF despite optimal medical treatment in accordance with current guidelines.
Atrial fibrillation (AF) is the most common cardiac arrhythmia (irregular heartbeat) affecting 3% of the population. AF is associated with poor quality of life (QoL) and large costs for society. In a considerable proportion of patients, AF symptoms (e.g., palpitations, fatigue, and chest pain) are not alleviated by current medical or interventional treatments. Psychological factors can worsen AF symptoms, and anxiety and depression are common among AF patients. Symptom preoccupation and avoidance of social and physical activities are likely to play important roles in the development of anxiety, depression, disability and healthcare utilization. The aim is to evaluate if CBT, based on behavioral activation and exposure principles, improves wellbeing and QoL in symptomatic AF patients more than a wait list offered treatment as usual. Method: A randomized controlled trial. Participants are randomized to internet-delivered CBT for 10 weeks (N=60) or to treatment as usual (N=60). The internet-delivered CBT-program will last for 10 weeks and include weekly therapist support, consisting of online messages and telephone calls. Patients on the treatment as usual wait list will be provided standardized written information about basic self-management in AF. The treatment as usual wait list will be crossed over to treatment 3 months after the treatment group has completed treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
126
The intervention lasts for 10 weeks and include: Education, Interoceptive exposure, exposure in-vivo, combining in-vivo exposure with interoceptive exposure, behavioral activation and relapse prevention. Include the guidance of a minimum weekly contact with a CBT psychologist.
Consist of standardized AF information that emphasizes that an active physical and social lifestyle is necessary to maintain good health, without the guidance of a psychologist or any CBT interventions.
Karolinska universitetssjukhuset Solna
Stockholm, Sweden
The Atrial Fibrillation Quality of Life (AFEQT)
The AFEQT is an atrial fibrillation-specific measure that taps into the QoL-domains: symptoms, daily activities, treatment concern, and treatment satisfaction.
Time frame: From baseline to 6 months PRIMARY ENDPOINT
The Atrial Fibrillation Quality of Life (AFEQT)
The AFEQT is an atrial fibrillation-specific measure that taps into the QoL-domains: symptoms, daily activities, treatment concern, and treatment satisfaction.
Time frame: From baseline to 12 weeks
The Atrial Fibrillation Quality of Life (AFEQT)
The AFEQT is an atrial fibrillation-specific measure that taps into the QoL-domains: symptoms, daily activities, treatment concern, and treatment satisfaction.
Time frame: From baseline to 9 months
The Atrial Fibrillation Quality of Life (AFEQT)
The AFEQT is an atrial fibrillation-specific measure that taps into the QoL-domains: symptoms, daily activities, treatment concern, and treatment satisfaction.
Time frame: From baseline to 15 months
Electrocardiography (ECG) measurement
Change in symptomatic burden. The patient will undergo 5 days ECG assessment in order to measure objectively symptomatic burden (number and duration of symptomatic AF episodes and symptomatic "non-AF episodes")
Time frame: From baseline to 12 weeks
ECG measurement
Change in symptomatic burden. The patient will undergo 5 days ECG assessment in order to measure objectively symptomatic burden (number and duration of symptomatic AF episodes and symptomatic "non-AF episodes")
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: From baseline to 6 months
ECG measurement
Change in symptomatic burden. The patient will undergo 5 days ECG assessment in order to measure objectively symptomatic burden (number and duration of symptomatic AF episodes and symptomatic "non-AF episodes")
Time frame: From baseline to 15 months
Cardiac Anxiety Questionary (CAQ)
Symptom preoccupation
Time frame: From baseline to 12 weeks
Cardiac Anxiety Questionary (CAQ)
Symptom preoccupation
Time frame: From baseline to 6 months
Cardiac Anxiety Questionary (CAQ)
Symptom preoccupation
Time frame: From baseline to 9 months
Cardiac Anxiety Questionary (CAQ)
Symptom preoccupation
Time frame: From baseline to 15 months
the World Health Organization Disability Assessment Schedule (WHODAS 2.0, 12- item version)
General quality of life
Time frame: From baseline to 12 weeks
WHODAS 2.0 (12-item version)
General quality of life
Time frame: From baseline to 6 months
WHODAS 2.0 (12-item version)
General quality of life
Time frame: From baseline to 15 months
Symptom checklist Severity and Frequency Scale (SCL)
AF related symptoms
Time frame: From baseline to 12 weeks
Symptom checklist Severity and Frequency Scale (SCL)
AF related symptoms
Time frame: From baseline to 6 months
Symptom checklist Severity and Frequency Scale (SCL)
AF related symptoms
Time frame: From baseline to 15 months
Atrial Fibrillation Severity Scale
Symptomatic burden
Time frame: From baseline to 12 weeks
Atrial Fibrillation Severity Scale
Symptomatic burden
Time frame: From baseline to 6 months
Atrial Fibrillation Severity Scale
Symptomatic burden
Time frame: From baseline to 15 months
Patient Health Questionnaire (PHQ-9)
Depression
Time frame: From baseline to 12 weeks
PHQ-9
Depression
Time frame: From baseline to 6 months
PHQ-9
Depression
Time frame: From baseline to 15 months
Client satisfaction Questionnaire
Treatment satisfaction
Time frame: From baseline to 12 weeks
Adverse events
Potential adverse reactions to the treatment
Time frame: From baseline to 12 weeks